Glucose variability inversely associates with endothelial progenitor cells in type 1 diabetes

Endocrine

Volumn 48, Issue 1, 2015, Pages 342-345

  Maiorino, Maria Ida ^a   Della Volpe, Elisabetta ^a   Olita, Laura ^a   Bellastella, Giuseppe ^a   Giugliano, Dario ^a   Esposito, Katherine ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GLUCOSE; HEMOGLOBIN A1C; VASCULOTROPIN RECEPTOR 2; GLUCOSE BLOOD LEVEL; GLYCOPROTEIN; GLYCOSYLATED HEMOGLOBIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADULT; BODY MASS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; PRIORITY JOURNAL; DIABETIC ANGIOPATHY; METABOLISM; OXIDATIVE STRESS; YOUNG ADULT;

ANTIGENS, CD; ANTIGENS, CD34; BLOOD GLUCOSE; CELL COUNT; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIAL PROGENITOR CELLS; FEMALE; GLUCOSE; GLYCOPROTEINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OXIDATIVE STRESS; PEPTIDES; YOUNG ADULT;

EID: 84922802319     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0277-z     Document Type: Letter

References (15)

1. F. Cavalot, Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes. Diabetes Obes. Metab. 15(Suppl 2), 3–8 (2013)
2. F. Picconi, A. Di Flaviani, I. Malandrucco, I. Giordani, S. Frontoni, Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. Nutr. Metab. Cardiovasc. Dis. 22, 691–696 (2012)
3. A. Ceriello, K. Esposito, L. Piconi, M.A. Ihnat, J.E. Thorpe, R. Testa, M. Boemi, D. Giugliano, Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57, 1349–1354 (2008)
4. A. Avogaro, M. Albiero, L. Menegazzo, S. de Kreutzenberg, G.P. Fadini, Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34(Suppl 2), S285–S290 (2011)
5. T. Hörtenhuber, B. Rami-Mehar, M. Satler, K. Nagl, C. Höbaus, F. Höllerl, R. Koppensteiner, G. Schernthaner, E. Schober, G.H. Schernthaner, Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care 36, 1647–1653 (2013)
6. K. Esposito, M.I. Maiorino, C. Di Palo, M. Gicchino, M. Petrizzo, G. Bellastella, F. Saccomanno, D. Giugliano, Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes: a randomized controlled trial. Diabetes Obes. Metab. 13, 439–445 (2011)
7. C. Dessapt, J. Karalliedde, M. Hernandez-Fuentes, P. Prieto Martin, G. Maltese, N. Dattani, R. Atkar, G. Viberti, L. Gnudi, Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care 33, 875–877 (2010)
8. L. Sibal, A. Aldibbiat, S.C. Agarwal, G. Mitchell, C. Oates, S. Razvi, J.U. Weaver, J.A. Shaw, P.D. Home, Circulating endothelial progenitor cells, endothelial function, carotid intima–media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 52, 1464–1473 (2009)
9. C. Palombo, M. Kozakova, C. Morizzo, L. Gnesi, M.C. Barsotti, P. Spontoni, F. Massart, P. Salvi, A. Balbarini, G. Saggese, R. Di Stefano, G. Federico, Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc. Diabetol. 10, 88 (2011)
10. G.P. Fadini, A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications. Diabetologia 57, 4–15 (2014)
11. M. Gili, A. Orsello, S. Gallo, M.F. Brizzi, Diabetes-associated macrovascular complications: cell-based therapy a new tool? Endocrine 44, 557–575 (2013)
12. N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Böhm, G. Nickenig, Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999–1007 (2005)
13. S. Sen, S.P. McDonald, P.T. Coates, C.S. Bonder, Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin. Sci. (Lond.) 120, 263–283 (2011)
14. G.P. Fadini, S.V. de Kreutzenberg, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur. Heart J. 27, 2247–2255 (2006)
15. G.P. Fadini, S. de Kreutzenberg, C. Agostini, E. Boscaro, A. Tiengo, S. Dimmeler, A. Avogaro, Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis 207, 213–219 (2009)